Heart Doc VIP with Dr. Joel Kahn cover image

Episode 486: Top 10 Takeaways of New Cholesterol Guidelines 2026

Heart Doc VIP with Dr. Joel Kahn

00:00

Eliquis Beats Xarelto for Bleeding Risk

Joel Kahn outlines the COBRA trial showing lower bleeding with apixaban (Eliquis) versus rivaroxaban (Xarelto) after DVT.

Play episode from 22:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app